JP2025518282A5 - - Google Patents

Info

Publication number
JP2025518282A5
JP2025518282A5 JP2024570980A JP2024570980A JP2025518282A5 JP 2025518282 A5 JP2025518282 A5 JP 2025518282A5 JP 2024570980 A JP2024570980 A JP 2024570980A JP 2024570980 A JP2024570980 A JP 2024570980A JP 2025518282 A5 JP2025518282 A5 JP 2025518282A5
Authority
JP
Japan
Prior art keywords
core
apolipoprotein
rna
polyvalent
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024570980A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025518282A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/064963 external-priority patent/WO2023233042A1/en
Publication of JP2025518282A publication Critical patent/JP2025518282A/ja
Publication of JP2025518282A5 publication Critical patent/JP2025518282A5/ja
Pending legal-status Critical Current

Links

JP2024570980A 2022-06-03 2023-06-05 核酸送達のための多価分子に基づく脂質ナノ粒子 Pending JP2025518282A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22177313.8 2022-06-03
EP22177313 2022-06-03
PCT/EP2023/064963 WO2023233042A1 (en) 2022-06-03 2023-06-05 Polyvalent molecule based lipid nanoparticles for nucleic acid delivery

Publications (2)

Publication Number Publication Date
JP2025518282A JP2025518282A (ja) 2025-06-12
JP2025518282A5 true JP2025518282A5 (cg-RX-API-DMAC7.html) 2026-04-14

Family

ID=81940594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024570980A Pending JP2025518282A (ja) 2022-06-03 2023-06-05 核酸送達のための多価分子に基づく脂質ナノ粒子

Country Status (10)

Country Link
US (1) US20250325491A1 (cg-RX-API-DMAC7.html)
EP (1) EP4531818A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025518282A (cg-RX-API-DMAC7.html)
KR (1) KR20250031158A (cg-RX-API-DMAC7.html)
CN (1) CN119522092A (cg-RX-API-DMAC7.html)
AU (1) AU2023278446A1 (cg-RX-API-DMAC7.html)
CA (1) CA3258109A1 (cg-RX-API-DMAC7.html)
IL (1) IL317412A (cg-RX-API-DMAC7.html)
MX (1) MX2024014961A (cg-RX-API-DMAC7.html)
WO (1) WO2023233042A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250121393A (ko) * 2022-12-12 2025-08-12 스타르나 테라퓨틱스 표적 전달을 위한 신규 화합물 및 이의 용도
US12343429B2 (en) 2023-10-05 2025-07-01 Nanovation Therapeutics Inc. Method of delivery of DNA or RNA cargo unshielded lipid nanoparticles and compositions thereof
WO2025245869A1 (zh) * 2024-05-31 2025-12-04 清华大学 含有精氨酸结构的可电离脂质分子、包含其的脂质纳米颗粒及其用途
CN119431176B (zh) * 2024-11-05 2026-02-13 汉信生物科技(苏州)有限公司 一种可电离阳离子脂质及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4995423B2 (ja) * 2002-12-03 2012-08-08 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート 物質を血液−脳関門を渡って輸送するための人工低密度リポタンパク質キャリア
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
KR102764250B1 (ko) 2015-09-14 2025-02-07 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 지질양이온성 덴드리머 및 이의 용도
CN114656378A (zh) * 2016-05-16 2022-06-24 得克萨斯州大学系统董事会 阳离子磺酰胺氨基脂质和两亲性两性离子氨基脂质
JP7330994B2 (ja) 2017-11-21 2023-08-22 アイカーン スクール オブ メディスン アット マウント サイナイ 治療用ナノ生物学的組成物による訓練免疫の促進
CN113616602B (zh) * 2021-08-31 2022-05-10 中国药科大学 一种重组高密度脂蛋白-聚酰胺-胺纳米复合物、制法及应用

Similar Documents

Publication Publication Date Title
US20230144623A1 (en) Systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic moiety
JP2024526202A5 (cg-RX-API-DMAC7.html)
CN105131067B (zh) 皮肤与纤维化症候中的rna干扰
JP2024152725A (ja) ハンチンチンmRNAをターゲティングするオリゴヌクレオチド化合物
CA3156176A1 (en) Oligonucleotide compositions and methods of use thereof
US9012225B2 (en) Lipophilic polynucleotide conjugates
EP2805713B1 (en) Magnetic nanoparticle-samirna complex and method for preparing same
CN112805004A (zh) 向人脂肪细胞靶向递送治疗剂
JP2020531418A (ja) 脂質ナノ粒子製剤における使用のための脂質
EP3003274B1 (en) Hydrophobically modified antisense oligonucleotides comprising a triple alkyl chain
CN105705638B (zh) 改善的具有高效能的纳米颗粒型寡核苷酸结构及其制备方法
EP2549980B1 (en) Reverse micelle system comprising nucleic acids and use thereof
JP2011517676A5 (cg-RX-API-DMAC7.html)
CN101874111B (zh) 利用内源性乳糜微粒递送用于抑制靶基因表达的核酸的体系
CN105960265A (zh) 利用经化学修饰的寡核苷酸处理伤口愈合的方法
WO2014195755A1 (en) Hydrophobically modified antisense oligonucleotides comprising a ketal group
CN114957164B (zh) 一种脂质化合物及其制备方法与应用
Puri et al. Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts
JP2026512620A (ja) イオン性脂質
TW202517616A (zh) 可離子化脂質
CN119285921B (zh) 用于脾选择性核酸递送的含氟聚合物、聚合物脂质杂化物纳米颗粒及其制备方法与应用
RU2022115894A (ru) Композиции и способы ингибирования экспрессии генов аполипопротеина c-iii (apoc3)
WO2024137726A2 (en) Compositions and methods for treating hnrnph2-related disorders
JP2025514327A5 (cg-RX-API-DMAC7.html)
CN119896747A (zh) 一种负载降低转甲状腺素蛋白核酸的含钙脂质纳米粒